Partner Headlines - TEVA

  1. Lilly Regains Key Migraine Drug With $960 Million CoLucid Acquisition

    Investors Business Daily
  2. Trump's 'Disastrous' Pharma View Doesn't Rattle JPMorgan Drug ...

    Investors Business Daily
  3. Eli Lilly Rebounds On Chemo-Drug Patent Win Vs. Generic Teva

    Investors Business Daily
  4. Drug Stocks Tank As Trump Vows To Attack High Drug Prices

    Investors Business Daily
  5. Drug Stocks Tank As Trump Vows To Attack High Drug Prices

    Investors Business Daily
  6. Morning Call For Monday, Jan. 9

    TalkMarkets
  7. Last London Letter

    TalkMarkets
  8. Mylan, Novartis, Hikma Take On GSK In Generic Asthma Battle

    Investors Business Daily
  9. Lilly Nears FDA Nod On Arthritis Drug, But Chemo Med Stuck In ...

    Investors Business Daily
  10. Amgen Plans Robust 2017 In Alzheimer's, Migraines, Oncology: ...

    Investors Business Daily
  11. Boxing Day

    TalkMarkets
  12. J&J Back In Talks With Actelion, Teva Settles Corruption Probe

    TalkMarkets
  13. Allergan Outlook Improves On Good Trial For Colon Drug: Credit ...

    Investors Business Daily
  14. Allergan Outlook Improves On Good Trial For Colon Drug: Credit ...

    Investors Business Daily
  15. Drastic Drug-Price Action No Trump Card, Says Needham

    Investors Business Daily
  16. Gilead Buying Alexion Tops Piper's Potential Events In 2017

    TalkMarkets
  17. Supernus Pharmaceuticals Breaks Out On Up Day For Biotech Stocks

    Investors Business Daily
  18. Week in Review: China Metallurgical Spending $531 Million to ...

    TalkMarkets
  19. Mylan Launching Cheaper EpiPen Generic Amid Drug Pricing Saga

    Investors Business Daily
  20. Does The Symbolism Of Dow 20K Affect Technical Analysis?

    TalkMarkets
  21. Mylan, Teva Among 6 Pharmas Sued In Alleged Price-Fixing Scheme

    Investors Business Daily
  22. DOJ Charges Pharma Execs With Price-Fixing; Teva, Mylan Stocks ...

    Investors Business Daily
  23. These 8 Top Dividend Stocks Are Also ADRs - Check Them Out

    TalkMarkets
  24. Trending: Key Management Departure at Teva; Booming Oil Prices

    Dividend.com
  25. Russian Oil, Renminbi Rumors And Global Stocks

    TalkMarkets
  26. Mylan Slumps After Disclosing Plans To Cut Workforce In Restructuring ...

    TalkMarkets
  27. TherapeuticsMD Soars On Positive Menopause Drug Trial Results

    Investors Business Daily
  28. 50 Companies Going Ex-Dividend This Week Including KO, PEP, HD, ...

    TalkMarkets
  29. Better Than The Maestro

    TalkMarkets
  30. Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal

    TalkMarkets
  31. A Stock Bubble

    TalkMarkets
  32. 6 Things You Need To Know About Teva's Q3 Earnings

    TalkMarkets
  33. Teva (TEVA) Q3 Earnings Top but Revenues Lag Estimates

    TalkMarkets
  34. 5 Stocks To Watch That Report Earnings Tomorrow - Tuesday, Nov. ...

    TalkMarkets
  35. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets
  36. Buy Health Care Now? It All Depends On The Election

    TalkMarkets
  37. Generic Drugs Probe Seen As Possible 'Severe' Sector Overhang ...

    TalkMarkets
  38. S&P 500 Index Posted Its 8th Consecutive Loss

    TalkMarkets
  39. Drugs, Finance, Cars, And Fuel

    TalkMarkets
  40. Why After A Massive Run, CoLucid Shares Still Look Attractive ...

    TalkMarkets
  41. Best Stock Charts - October 30, 2016

    TalkMarkets
  42. Teva, IBM announce significant expansion of e-Health alliance ...

    TalkMarkets
  43. Global Roundup: Roche, Vale, Novo Nordisk, Teva, Benitec Et Al ...

    TalkMarkets
  44. 7 Drug Stocks To Consider As Biosimilars Pick Up Pace

    TalkMarkets
  45. Clarifying Confusion Over Mylan's EpiPen Profits

    TalkMarkets
  46. Week In Review: Teva Pays $160 Million For US/Canada Rights To ...

    TalkMarkets
  47. Has Gold Lost Its Glimmer?

    TalkMarkets
  48. The Internet Of Medical Things: 6 Stocks In Focus

    TalkMarkets
  49. How Will Healthcare Stocks Be Affected If Donald Trump Wins?

    Dividend.com
  50. How Will Healthcare Stocks Be Affected If Hillary Clinton Wins?

    Dividend.com
  51. Alder Biopharma Migraine Drug Holds Up After 6 Months

    Investors Business Daily
  52. California Leads Nation In Tech, Lifesciences IPOs

    IBD
  53. Gurus Are Buying High-Yield Stocks Like WestRock, Target

    GuruFocus
  54. Top Stocks 2015: Biotechs, Wayfair, Netflix, Amazon

    IBD
  55. Takeda Provides Update About New Business Venture in Japan with ...

    Benzinga
  56. 5 Guru Picks in Volatile Biotech Industry

    GuruFocus
  57. NWQ Managers Reduces Stakes in Microsoft, MetLife and Teva Pharmaceutical

    GuruFocus
  58. Benzinga's Top Initiations

    Benzinga
  59. GoPro PT Cut; Chipotle, Bluebird Bio Downgraded

    IBD
  60. Benzinga's Volume Movers

    Benzinga
  61. Top Performing Industries For December 1, 2015

    Benzinga
  62. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga
  63. Teva Announces Proposed Public Offerings Of Amer Depositary Shrs ...

    Benzinga
  64. Teva, Takeda Establish Partnership in Japan; Teva to Own 51% ...

    Benzinga
  65. Teva, Heptares Announce Agreement to Discover and Develop Novel, ...

    Benzinga
  66. Benzinga's Top Upgrades

    Benzinga
  67. Pfizer, Allergan Set To Unveil $150 Billion Inversion

    IBD
  68. John Paulson Increases Holding in Teva Pharmaceutical

    GuruFocus
  69. John Paulson Keeps Gold, Buys Drug Manufacturers in Q3

    GuruFocus
  70. Mylan, Perrigo Face Off As Takeover Vote Nears

    IBD
  71. Ronald Muhlenkamp's Highest-Yielding Stocks

    GuruFocus
  72. Teva Announces Breakthrough Therapy Designation for SD-809 Granted ...

    Benzinga
  73. Allergan Beats Q3 Estimates Amid M&A, Pricing Talk

    IBD
  74. Roche Touts New MS Drug As Legacy Players Hit Snags

    IBD
  75. Allergan Confirms Pfizer Talks

    IBD
  76. Teva Pharmaceutical's

    IBD
  77. Ah the Joys of Theft - My Purloined Portfolio

    GuruFocus
  78. Here's Why Biotechs Fell On Monday

    Benzinga
  79. Teva Launches Generic Avodart Capsules in the US

    Benzinga
  80. Neurocrine Tardive Dyskinesia Drug Hits, Stock Jumps

    IBD
  81. Acorda, Allergan Make Surprise Deal On Ampyra Patent

    IBD
  82. Benzinga's M&A Chatter for Thursday October 1, 2015

    Benzinga
  83. Allergan Guidance Update Gets Mixed Reception

    IBD
  84. U.S. M&A Hits Record As Companies Try To Grow Sales

    IBD
  85. Teva Announces COPAXONE Approved in Japan for Prevention of Relapse ...

    Benzinga
  86. Teva Presents New Reslizumab Data at ERS International Congress ...

    Benzinga
  87. Hedge Fund Menta Capital's Top Stocks Include Teva Pharmaceutical, ...

    GuruFocus
  88. An ETF That Provides Shelter From Stormy Markets

    Benzinga
  89. Teva Announces U.S. Availability of ZECUITY® (sumatriptan iontophoretic ...

    Benzinga
  90. Mylan Confirms USPTO Institutes Inter Partes Review Proceedings ...

    Benzinga
  91. Allergan Modestly Tops Views

    IBD
  92. Allergan Q2 Beats, But Generics Sale Clouds Outlook

    IBD
  93. Israeli Tech Startups Attract Record Funding In Q2

    IBD
  94. 5 Top Medical Stocks Reporting Earnings This Week

    IBD
  95. Teva's Deal-Making Spurs Inflows To Israel ETFs

    Benzinga
  96. Benzinga's Top Upgrades

    Benzinga
  97. IBD 50: 10 Top Stocks Reporting Earnings This Week

    IBD
  98. These 4 Foreign Drug Stocks Have Broken Out Recently

    IBD
  99. 5 Hot Drug Stocks Top IBD's Big Cap Leaders Screen

    IBD
  100. Wakefulness Drug Xyrem Keeps Jazz Pharmaceuticals Up

    IBD
Trading Center